Financial Statements

Johnson & Johnson (JNJ)

$175.5

-3.32 (-1.86%)
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers are in thousands

Retained Earning Schedule

Year 2022 2021 2019 2018 2017
Retained Earnings (Previous Year) 113,890-106,216101,793-
Net Income 20,87814,71415,11915,2971,300
Stock Dividends -676109,657-759-1,380109,436
Dividend Paid -11,032-10,481-9,917-9,494-8,943
Retained Earnings 123,060113,890110,659106,216101,793

PPE Schedule

Year 2022 2021 2019 2018 2017
Gross PPE 18,766-17,03517,005-
Annual Depreciation 3,84822,1135,0783,70020,284
Capital Expenditure -3,652-3,347-3,498-3,670-3,279
Net PPE 18,96218,76618,61517,03517,005

Intangible and Goodwill Schedule

Year 2022 2021 2019 2018 2017
Intangible and Goodwill (Previous Year) -31,90630,453-36,393
New Purchases -6,153-5,626-3,920-21,089-30,394
Intangible and Goodwill 31,90630,45333,63936,39335,246

Johnson & Johnson income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Johnson & Johnson FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.